[HTML][HTML] Efficacy and safety of Morinda officinalis oligosaccharide capsules for depressive disorder: a systematic review and meta-analysis

Y Du, Q Zheng, ZH Ou, YJ Cao, XP Su, C Li… - Brazilian Journal of …, 2020 - SciELO Brasil
Objective: To evaluate the efficacy and safety of Morinda officinalis oligosaccharide (MOO)
capsules for depressive disorder. Methods: Eight electronic databases were searched for …

Unraveling the potential of Morinda officinalis oligosaccharides as an adjuvant of escitalopram in depression treatment and exploring the underlying mechanisms

SM Pan, XY Yin, DM Dai, LW Zhang, Q Qi… - Journal of …, 2024 - Elsevier
Ethnophamacological relevance Morinda officinalis oligosaccharides (MOs) is a mixture of
oligosaccharides extracted from the roots of Morinda officinalis (MO). It is approved by …

Isolation, phytochemistry, characterization, biological activity, and application of Morinda officinalis How oligosaccharide: a review

J Yue, W Xia, Y Wang, Y Zhang, Y Zhang… - Journal of Pharmacy …, 2024 - academic.oup.com
Morinda officinalis How oligosaccharide (MOO) stands as one of the principal active
constituents of M. officinalis How, widely employed in traditional Chinese medicine. The …

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - journals.sagepub.com
Background: Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …

[PDF][PDF] Research of Morinda officinalis how's oligosaccharide extraction and antidepressant effects

X Li, SY Ma, D Cheng, HS Chang, LL Li, Y Lu - Bulgar. Chem. Commun., 2017 - bcc.bas.bg
Research of Morinda officinalis how’s oligosaccharide extraction and antidepressant effects
Page 160 Bulgarian Chemical Communications, Volume 49, Special Edition K2,(pp. 162–167) …

A systematic review on polysaccharides from Morinda officinalis How: Advances in the preparation, structural characterization and pharmacological activities

M Liu, C Wang, H Zhang, H Guo, L Kang, H Li… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Morinda officinalis How is called “Ba-Ji-Tian” in
Traditional Chinese Medicine (TCM), which belongs to the genus Rubiaceae and is widely …

[HTML][HTML] Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut …

ZW Zhang, CS Gao, H Zhang, J Yang, YP Wang… - … Pharmaceutica Sinica B, 2022 - Elsevier
Morinda officinalis oligosaccharides (MOO) are an oral drug approved in China for the
treatment of depression in China. However, MOO is hardly absorbed so that their anti …

Morita therapy for depression in adults: A systematic review and meta-analysis

Y Jia, M Li, Z Cheng, L Cui, J Zhao, Y Liu, M Leng… - Psychiatry …, 2018 - Elsevier
Morita therapy is a systematic psychological therapy that aims to improve everyday
functioning rather than target specific symptoms. However, there has been no systematic …

[HTML][HTML] Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: a PRISMA-compliant meta-analysis of randomized controlled trials

T Wu, T Yue, P Yang, Y Jia - Journal of Ethnopharmacology, 2022 - Elsevier
Ethnopharmacological relevance Post stroke depression (PSD), which happens in 40%–
60% stroke patients, is one of the most common complications after cerebrovascular …

Effect-enhancing and toxicity-reducing effects of Chaihu Jia Longgu Muli decoction in the treatment of multimorbidity with depression: a systematic review and meta …

X Jia, J Chen, R Huang, D Wang… - Pharmaceutical Biology, 2023 - Taylor & Francis
Abstract Context Chaihu Jia Longgu Muli Decoction (CLMD) is a traditional Chinese
medicine for treating depression. Objective This study investigated the effect of CLMD …